A reversible model of the cognitive impairment associated with schizophrenia in monkeys: Potential therapeutic effects of two nicotinic acetylcholine receptor agonists

This publication has 49 references indexed in Scilit:

• Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia
  Psychopharmacology, 2004
• Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia
  Psychopharmacology, 2004
• Schizophrenia: the fundamental questions
  Brain Research Reviews, 2000
• Ketamine: review of its pharmacology and its use in pediatric anesthesia.
  1999
• Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking
  Biochemical Pharmacology, 1997
• 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat α7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner
  Brain Research, 1997
• Safety of Cotinine in Humans: Physiologic, Subjective, and Cognitive Effects
  Pharmacology Biochemistry and Behavior, 1997
• Functional Characterization of the Novel Neuronal Nicotinic Acetylcholine Receptor Ligand GTS-21 In Vitro and In Vivo
  Pharmacology Biochemistry and Behavior, 1997
• Interaction of the Chiral Forms of Ketamine with Opioid, Phencyclidine, σ and Muscarinic Receptors
  Basic & Clinical Pharmacology & Toxicology, 1995
• The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers
  European Journal of Clinical Pharmacology, 1990